Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

BACKGROUND: In the U.S., lung cancer accounts for 14% of cancer diagnoses and 28% of cancer deaths annually. Since no cure exists for advanced lung cancer, the main treatment goal is to prolong survival. Chemotherapy regimens produce side effects with different profiles. Coupling this with individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, K. M., Anggondowati, T., Deviany, P. E., Ryan, J. E., Fetrick, A., Bagenda, D., Copur, M. S., Tolentino, A., Vaziri, I., McKean, H. A., Dunder, S., Gray, J. E., Huang, C., Ganti, A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712837/
https://www.ncbi.nlm.nih.gov/pubmed/31455252
http://dx.doi.org/10.1186/s12885-019-6054-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712837/
https://www.ncbi.nlm.nih.gov/pubmed/31455252
http://dx.doi.org/10.1186/s12885-019-6054-x

Ejemplares similares